| 1 | Palmitate potentiates the SMAD3-PAI-1 pathway by reducing nuclear GDF15 levels | 5.5 | 1 | Citations (PDF) |
| 2 | Liver gene expression and its rewiring in hepatic steatosis are controlled by PI3Kα-dependent hepatocyte signaling | 5.0 | 3 | Citations (PDF) |
| 3 | Targeting AMPK as a potential treatment for hepatic fibrosis in MASLD | 11.4 | 31 | Citations (PDF) |
| 4 | GDF15 activates AMPK and inhibits gluconeogenesis and fibrosis in the liver by attenuating the TGF-β1/SMAD3 pathway | 9.1 | 39 | Citations (PDF) |
| 5 | The Opioid Receptor Influences Circadian Rhythms in Human Keratinocytes through the β-Arrestin Pathway | 4.6 | 4 | Citations (PDF) |
| 6 | Increased hepatic gluconeogenesis and type 2 diabetes mellitus | 8.5 | 53 | Citations (PDF) |
| 7 | PPARβ/δ attenuates hepatic fibrosis by reducing SMAD3 phosphorylation and p300 levels via AMPK in hepatic stellate cells | 6.6 | 24 | Citations (PDF) |
| 8 | Lipid sensing by PPARα: Role in controlling hepatocyte gene regulatory networks and the metabolic response to fasting | 14.3 | 38 | Citations (PDF) |
| 9 | PPARβ/δ upregulates the insulin receptor β subunit in skeletal muscle by reducing lysosomal activity and EphB4 levels | 7.9 | 4 | Citations (PDF) |
| 10 | A positive feedback loop between AMPK and GDF15 promotes metformin antidiabetic effects | 9.1 | 36 | Citations (PDF) |
| 11 | Striking a gut–liver balance for the antidiabetic effects of metformin | 11.4 | 11 | Citations (PDF) |
| 12 | Elafibranor upregulates the EMT-inducer S100A4 via PPARβ/δ | 6.6 | 17 | Citations (PDF) |
| 13 | Integrative study of diet-induced mouse models of NAFLD identifies PPARα as a sexually dimorphic drug target | 16.8 | 78 | Citations (PDF) |
| 14 | Adipose-Specific PPARα Knockout Mice Have Increased Lipogenesis by PASK–SREBP1 Signaling and a Polarity Shift to Inflammatory Macrophages in White Adipose Tissue | 4.6 | 70 | Citations (PDF) |
| 15 | Role of Dietary Supplements and Probiotics in Modulating Microbiota and Bone Health: The Gut-Bone Axis | 4.6 | 117 | Citations (PDF) |
| 16 | Nuclear HMGB1 protects from nonalcoholic fatty liver disease through negative regulation of liver X receptor | 10.9 | 20 | Citations (PDF) |
| 17 | The Loss of PPARα in Adipocytes Induces Lipogenesis via the PASK‐SREBP1 Signaling Axis | 0.6 | 0 | Citations (PDF) |
| 18 | Peroxisomal Proliferator-Activated Receptor β/δ Deficiency Induces Cognitive Alterations | 3.8 | 9 | Citations (PDF) |
| 19 | Knocking on GDF15’s door for the treatment of type 2 diabetes mellitus | 8.5 | 42 | Citations (PDF) |
| 20 | Invalidation of the Transcriptional Modulator of Lipid Metabolism PPARβ/δ in T Cells Prevents Age-Related Alteration of Body Composition and Loss of Endurance Capacity | 2.8 | 6 | Citations (PDF) |
| 21 | The pregnane X receptor drives sexually dimorphic hepatic changes in lipid and xenobiotic metabolism in response to gut microbiota in mice | 11.5 | 29 | Citations (PDF) |
| 22 | PPARs and Tumor Microenvironment: The Emerging Roles of the Metabolic Master Regulators in Tumor Stromal–Epithelial Crosstalk and Carcinogenesis | 3.8 | 73 | Citations (PDF) |
| 23 | LRG1 Promotes Metastatic Dissemination of Melanoma through Regulating EGFR/STAT3 Signalling | 3.8 | 33 | Citations (PDF) |
| 24 | Roles of Estrogens in the Healthy and Diseased Oviparous Vertebrate Liver | 3.4 | 22 | Citations (PDF) |
| 25 | The PPARβ/δ-AMPK Connection in the Treatment of Insulin Resistance | 4.4 | 34 | Citations (PDF) |
| 26 | GDF15 mediates the metabolic effects of PPARβ/δ by activating AMPK | 6.3 | 98 | Citations (PDF) |
| 27 | Mechanistic definition of the cardiovascular mPGES-1/COX-2/ADMA axis | 5.5 | 24 | Citations (PDF) |
| 28 | Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease | 4.6 | 123 | Citations (PDF) |
| 29 | Peroxisome Proliferator-Activated Receptors as Molecular Links between Caloric Restriction and Circadian Rhythm | 4.4 | 33 | Citations (PDF) |
| 30 | Peroxisome Proliferator-Activated Receptors and Caloric Restriction—Common Pathways Affecting Metabolism, Health, and Longevity | 4.6 | 77 | Citations (PDF) |
| 31 | PPARs and Microbiota in Skeletal Muscle Health and Wasting | 4.4 | 90 | Citations (PDF) |
| 32 | Deficiency in fibroblast PPARβ/δ reduces nonmelanoma skin cancers in mice | 13.3 | 13 | Citations (PDF) |
| 33 | Exploring Extracellular Vesicles Biogenesis in Hypothalamic Cells through a Heavy Isotope Pulse/Trace Proteomic Approach | 4.6 | 16 | Citations (PDF) |
| 34 | PPARβ/δ Agonism Upregulates Forkhead Box A2 to Reduce Inflammation in C2C12 Myoblasts and in Skeletal Muscle | 4.4 | 14 | Citations (PDF) |
| 35 | Investigating the Role of PPARβ/δ in Retinal Vascular Remodeling Using Pparβ/δ-Deficient Mice | 4.4 | 7 | Citations (PDF) |
| 36 | Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity | 3.4 | 137 | Citations (PDF) |
| 37 | Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants | 4.2 | 144 | Citations (PDF) |
| 38 | The gut microbiota influences skeletal muscle mass and function in mice | 12.5 | 517 | Citations (PDF) |
| 39 | Pharmacological PPARβ/δ activation upregulates VLDLR in hepatocytes | 0.1 | 2 | Citations (PDF) |
| 40 | The Potential of the FSP1cre-Pparb/d−/− Mouse Model for Studying Juvenile NAFLD | 4.4 | 6 | Citations (PDF) |
| 41 | Hepatic PPARα is critical in the metabolic adaptation to sepsis | 4.2 | 88 | Citations (PDF) |
| 42 | The PPAR–microbiota–metabolic organ trilogy to fine‐tune physiology | 0.6 | 77 | Citations (PDF) |
| 43 | The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential | 9.4 | 127 | Citations (PDF) |
| 44 | Exploiting vulnerabilities of cancer by targeting nuclear receptors of stromal cells in tumor microenvironment | 29.2 | 69 | Citations (PDF) |
| 45 | Depletion of Gram-Positive Bacteria Impacts Hepatic Biological Functions During the Light Phase | 4.4 | 12 | Citations (PDF) |
| 46 | Collaborative Regulation of LRG1 by TGF-β1 and PPAR-β/δ Modulates Chronic Pressure Overload–Induced Cardiac Fibrosis | 4.4 | 43 | Citations (PDF) |
| 47 | Pharmacological PPARβ/δ activation upregulates VLDLR in hepatocytes | 0.4 | 10 | Citations (PDF) |
| 48 | Selective deletion of PPARβ/δ in fibroblasts causes dermal fibrosis by attenuated LRG1 expression | 7.9 | 36 | Citations (PDF) |
| 49 | Peroxisome Proliferator Activated Receptor Gamma Controls Mature Brown Adipocyte Inducibility through Glycerol Kinase | 6.3 | 106 | Citations (PDF) |
| 50 | ROS release by PPARβ/δ-null fibroblasts reduces tumor load through epithelial antioxidant response | 6.5 | 15 | Citations (PDF) |
| 51 | Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease | 5.9 | 110 | Citations (PDF) |
| 52 | Cyclooxygenase-2 Selectively Controls Renal Blood Flow Through a Novel PPARβ/δ-Dependent Vasodilator Pathway | 6.6 | 42 | Citations (PDF) |
| 53 | Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models | 3.9 | 201 | Citations (PDF) |
| 54 | Insights into the role of hepatocyte PPARα activity in response to fasting | 3.4 | 63 | Citations (PDF) |
| 55 | The Role of PPARβ/δ in Melanoma Metastasis | 4.4 | 25 | Citations (PDF) |
| 56 | The OEA effect on food intake is independent from the presence of PPARα in the intestine and the nodose ganglion, while the impact of OEA on energy expenditure requires the presence of PPARα in mice | 9.1 | 15 | Citations (PDF) |
| 57 | Enteric Microbiota–Gut–Brain Axis from the Perspective of Nuclear Receptors | 4.4 | 33 | Citations (PDF) |
| 58 | Complementary intestinal mucosa and microbiota responses to caloric restriction | 3.4 | 46 | Citations (PDF) |
| 59 | Insights into the Role of PPARβ/δ in NAFLD | 4.4 | 52 | Citations (PDF) |
| 60 | Metronidazole Causes Skeletal Muscle Atrophy and Modulates Muscle Chronometabolism | 4.4 | 65 | Citations (PDF) |
| 61 | Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome | 3.7 | 62 | Citations (PDF) |
| 62 | Roles of Peroxisome Proliferator-Activated Receptor β/δ in skeletal muscle physiology | 2.9 | 76 | Citations (PDF) |
| 63 | A Specific ChREBP and PPARα Cross-Talk Is Required for the Glucose-Mediated FGF21 Response | 6.3 | 124 | Citations (PDF) |
| 64 | PPARγ Modulates Long Chain Fatty Acid Processing in the Intestinal Epithelium | 4.4 | 52 | Citations (PDF) |
| 65 | Hepatic Fasting-Induced PPARα Activity Does Not Depend on Essential Fatty Acids | 4.4 | 11 | Citations (PDF) |
| 66 | Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD | 16.8 | 691 | Citations (PDF) |
| 67 | Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ | 14.3 | 67 | Citations (PDF) |
| 68 | Heme-Regulated eIF2α Kinase Modulates Hepatic FGF21 and Is Activated by PPARβ/δ Deficiency | 4.2 | 38 | Citations (PDF) |
| 69 | High-fat diet modifies the PPAR-γ pathway leading to disruption of microbial and physiological ecosystem in murine small intestine | 7.5 | 232 | Citations (PDF) |
| 70 | Intestinal PPARγ signalling is required for sympathetic nervous system activation in response to caloric restriction | 3.4 | 25 | Citations (PDF) |
| 71 | Hepatic circadian clock oscillators and nuclear receptors integrate microbiome-derived signals | 3.4 | 113 | Citations (PDF) |
| 72 | Peroxisome proliferator-activated receptor β/δ induces myogenesis by modulating myostatin activity. | 2.2 | 0 | Citations (PDF) |
| 73 | PPAR-β/δ activation promotes phospholipid transfer protein expression | 5.1 | 28 | Citations (PDF) |
| 74 | PPAR-beta/delta activation promotes phospholipid transfer protein expression | 1.5 | 0 | Citations (PDF) |
| 75 | Inactivation of PPARβ/δ adversely affects satellite cells and reduces postnatal myogenesis | 3.0 | 23 | Citations (PDF) |
| 76 | PPARβ/δ ameliorates fructose-induced insulin resistance in adipocytes by preventing Nrf2 activation | 4.1 | 25 | Citations (PDF) |
| 77 | Nuclear receptor peroxisome proliferator activated receptor (PPAR) β/δ in skin wound healing and cancer | 0.6 | 29 | Citations (PDF) |
| 78 | Absence of Intestinal PPARγ Aggravates Acute Infectious Colitis in Mice through a Lipocalin-2–Dependent Pathway | 4.4 | 44 | Citations (PDF) |
| 79 | Src is activated by the nuclear receptor peroxisome proliferator‐activated receptor β/δ in ultraviolet radiation‐induced skin cancer | 7.1 | 60 | Citations (PDF) |
| 80 | The coactivator PGC-1α regulates skeletal muscle oxidative metabolism independently of the nuclear receptor PPARβ/δ in sedentary mice fed a regular chow diet | 7.5 | 17 | Citations (PDF) |
| 81 | PPARβ/δ prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism | 7.5 | 98 | Citations (PDF) |
| 82 | Myostatin Augments Muscle-Specific Ring Finger Protein-1 Expression Through an NF-kB Independent Mechanism in SMAD3 Null Muscle | 2.5 | 40 | Citations (PDF) |
| 83 | PPARβ/δ attenuates palmitate-induced endoplasmic reticulum stress and induces autophagic markers in human cardiac cells | 2.2 | 64 | Citations (PDF) |
| 84 | PPARβ/δ is not required by PGC‐1α to enhance skeletal muscle oxidative metabolism (1164.3) | 0.6 | 0 | Citations (PDF) |
| 85 | Nutrigenomic foods | 0.6 | 7 | Citations (PDF) |
| 86 | Tau hyperphosphorylation and increased BACE1 and RAGE levels in the cortex of PPARβ/δ-null mice | 4.1 | 41 | Citations (PDF) |
| 87 | Role of the circadian clock gene Per2 in adaptation to cold temperature | 5.9 | 121 | Citations (PDF) |
| 88 | The Peroxisomal Enzyme L-PBE Is Required to Prevent the Dietary Toxicity of Medium-Chain Fatty Acids | 6.3 | 59 | Citations (PDF) |
| 89 | Contributions of peroxisome proliferator-activated receptor β/δ to skin health and disease | 2.6 | 12 | Citations (PDF) |
| 90 | Studying Wound Repair in the Mouse | 3.1 | 34 | Citations (PDF) |
| 91 | PPARβ Interprets a Chromatin Signature of Pluripotency to Promote Embryonic Differentiation at Gastrulation | 2.3 | 7 | Citations (PDF) |
| 92 | Lack of Smad3 signaling leads to impaired skeletal muscle regeneration | 3.0 | 49 | Citations (PDF) |
| 93 | Peroxisome Proliferator-activated Receptor β/δ Induces Myogenesis by Modulating Myostatin Activity | 2.2 | 28 | Citations (PDF) |
| 94 | The nuclear hormone receptor PPARγ counteracts vascular calcification by inhibiting Wnt5a signalling in vascular smooth muscle cells | 13.7 | 87 | Citations (PDF) |
| 95 | La activación de receptor activado por proliferadores peroxisómicos β/δ mejora la resistencia a insulina inducida por IL-6 en células hepáticas | 0.4 | 0 | Citations (PDF) |
| 96 | PPARs at the crossroads of lipid signaling and inflammation | 8.5 | 627 | Citations (PDF) |
| 97 | PPARβ/δ atenúa la respuesta inflamatoria inducida por lípidos en el corazón a través de un mecanismo de transrepresión por antagonismo de receptores | 0.4 | 0 | Citations (PDF) |
| 98 | GW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation | 5.5 | 81 | Citations (PDF) |
| 99 | PPARβ/δ affects pancreatic β cell mass and insulin secretion in mice | 10.6 | 52 | Citations (PDF) |
| 100 | Hepatic Deficiency in Transcriptional Cofactor TBL1 Promotes Liver Steatosis and Hypertriglyceridemia | 25.2 | 58 | Citations (PDF) |
| 101 | Sex differences in nuclear receptor-regulated liver metabolic pathways | 4.1 | 74 | Citations (PDF) |
| 102 | PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells | 2.4 | 74 | Citations (PDF) |
| 103 | New insights into the role of PPARs | 2.7 | 53 | Citations (PDF) |
| 104 | Smad3 signaling is required for satellite cell function and myogenic differentiation of myoblasts | 12.4 | 99 | Citations (PDF) |
| 105 | Smad3 Deficiency in Mice Protects Against Insulin Resistance and Obesity Induced by a High-Fat Diet | 4.2 | 139 | Citations (PDF) |
| 106 | Activation of Peroxisome Proliferator–Activated Receptor-β/-δ (PPAR-β/-δ) Ameliorates Insulin Signaling and Reduces SOCS3 Levels by Inhibiting STAT3 in Interleukin-6–Stimulated Adipocytes | 4.2 | 71 | Citations (PDF) |
| 107 | Proline- and acidic amino acid-rich basic leucine zipper proteins modulate peroxisome proliferator-activated receptor α (PPARα) activity | 7.5 | 78 | Citations (PDF) |
| 108 | Beneficial effects of combinatorial micronutrition on body fat and atherosclerosis in mice | 5.5 | 6 | Citations (PDF) |
| 109 | The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells | 7.5 | 78 | Citations (PDF) |
| 110 | Mechanisms of the Anti-Obesity Effects of Oxytocin in Diet-Induced Obese Rats | 2.3 | 245 | Citations (PDF) |
| 111 | PPAR Modulation of Kinase-Linked Receptor Signaling in Physiology and Disease | 5.0 | 19 | Citations (PDF) |
| 112 | Peroxisome proliferator-activated receptor β/δ: a master regulator of metabolic pathways in skeletal muscle | 1.1 | 3 | Citations (PDF) |
| 113 | A Concerted Kinase Interplay Identifies PPARγ as a Molecular Target of Ghrelin Signaling in Macrophages | 2.3 | 37 | Citations (PDF) |
| 114 | Regulation of epithelial–mesenchymal IL-1 signaling by PPARβ/δ is essential for skin homeostasis and wound healing | 5.4 | 105 | Citations (PDF) |
| 115 | Fatty Acid Synthesis and PPARα Hand in Hand | 4.7 | 14 | Citations (PDF) |
| 116 | Atherosclerotic mice exhibit systemic inflammation in periadventitial and visceral adipose tissue, liver, and pancreatic islets | 1.5 | 73 | Citations (PDF) |
| 117 | Sumoylated PPARα mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice | 10.6 | 113 | Citations (PDF) |
| 118 | Loss of Egg Yolk Genes in Mammals and the Origin of Lactation and Placentation | 5.0 | 146 | Citations (PDF) |
| 119 | PPARs Mediate Lipid Signaling in Inflammation and Cancer | 6.2 | 107 | Citations (PDF) |
| 120 | The Nuclear Hormone Receptor Peroxisome Proliferator-Activated Receptor β/δ Potentiates Cell Chemotactism, Polarization, and Migration | 2.5 | 64 | Citations (PDF) |
| 121 | Adipose Tissue Integrity as a Prerequisite for Systemic Energy Balance | 2.2 | 39 | Citations (PDF) |
| 122 | The Endocrine Disruptor Monoethyl-hexyl-phthalate Is a Selective Peroxisome Proliferator-activated Receptor γ Modulator That Promotes Adipogenesis | 2.2 | 337 | Citations (PDF) |
| 123 | Combined Simulation and Mutagenesis Analyses Reveal the Involvement of Key Residues for Peroxisome Proliferator-activated Receptorα Helix 12 Dynamic Behavior | 2.2 | 33 | Citations (PDF) |
| 124 | Stage-specific Integration of Maternal and Embryonic Peroxisome Proliferator-activated Receptor δ Signaling Is Critical to Pregnancy Success | 2.2 | 58 | Citations (PDF) |
| 125 | Association with Coregulators Is the Major Determinant Governing Peroxisome Proliferator-activated Receptor Mobility in Living Cells | 2.2 | 42 | Citations (PDF) |
| 126 | Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease | 2.4 | 164 | Citations (PDF) |
| 127 | The Interleukin-1 receptor antagonist is a direct target gene of PPARα in liver | 4.2 | 74 | Citations (PDF) |
| 128 | Roles of the peroxisome proliferator-activated receptor (PPAR) α and β/δ in skin wound healing | 0.2 | 3 | Citations (PDF) |
| 129 | IL-13 induces expression of CD36 in human monocytes through PPARγ activation | 3.1 | 86 | Citations (PDF) |
| 130 | Malignant Transformation of DMBA/TPA-Induced Papillomas and Nevi in the Skin of Mice Selectively Lacking Retinoid-X-Receptor α in Epidermal Keratinocytes | 2.3 | 83 | Citations (PDF) |
| 131 | Fat poetry: a kingdom for PPARγ | 12.4 | 142 | Citations (PDF) |
| 132 | Glycogen synthase 2 is a novel target gene of peroxisome proliferator-activated receptors | 5.5 | 73 | Citations (PDF) |
| 133 | Transcriptional Regulation of Metabolism | 25.4 | 826 | Citations (PDF) |
| 134 | PPARβ/δ Regulates Paneth Cell Differentiation Via Controlling the Hedgehog Signaling Pathway | 0.9 | 105 | Citations (PDF) |
| 135 | PGC1α expression is controlled in skeletal muscles by PPARβ, whose ablation results in fiber-type switching, obesity, and type 2 diabetes | 25.2 | 361 | Citations (PDF) |
| 136 | From molecular action to physiological outputs: Peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions | 14.3 | 707 | Citations (PDF) |
| 137 | PPARs in fetal and early postnatal development | 0.4 | 4 | Citations (PDF) |
| 138 | Physiological ligands of PPARs in inflammation and lipid homeostasis | 0.8 | 11 | Citations (PDF) |
| 139 | Functions of the Peroxisome Proliferator-Activated Receptor (PPAR) α and β in Skin Homeostasis, Epithelial Repair, and Morphogenesis | 1.8 | 56 | Citations (PDF) |
| 140 | A Growth Hormone-Releasing Peptide that Binds Scavenger Receptor CD36 and Ghrelin Receptor Up-Regulates Sterol Transporters and Cholesterol Efflux in Macrophages through a Peroxisome Proliferator-Activated Receptor γ-Dependent Pathway | 2.5 | 72 | Citations (PDF) |
| 141 | Role of Prostacyclin versus Peroxisome Proliferator-Activated Receptor β Receptors in Prostacyclin Sensing by Lung Fibroblasts | 3.8 | 87 | Citations (PDF) |
| 142 | Peroxisome Proliferator-Activated Receptor-α-Null Mice Have Increased White Adipose Tissue Glucose Utilization, GLUT4, and Fat Mass: Role in Liver and Brain | 2.5 | 73 | Citations (PDF) |
| 143 | Differentiation of Trophoblast Giant Cells and Their Metabolic Functions Are Dependent on Peroxisome Proliferator-Activated Receptor β/δ | 2.5 | 188 | Citations (PDF) |
| 144 | Reciprocal Regulation of Brain and Muscle Arnt-Like Protein 1 and Peroxisome Proliferator-Activated Receptor α Defines a Novel Positive Feedback Loop in the Rodent Liver Circadian Clock | 2.5 | 347 | Citations (PDF) |
| 145 | Crosstalk between peroxisome proliferator-activated receptor and VEGF stimulates cancer progression | 7.5 | 175 | Citations (PDF) |
| 146 | International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors | 15.7 | 928 | Citations (PDF) |
| 147 | The Fasting-induced Adipose Factor/Angiopoietin-like Protein 4 Is Physically Associated with Lipoproteins and Governs Plasma Lipid Levels and Adiposity | 2.2 | 393 | Citations (PDF) |
| 148 | Involvement of PPAR nuclear receptors in tissue injury and wound repair | 10.6 | 213 | Citations (PDF) |
| 149 | The G0/G1 switch gene 2 is a novel PPAR target gene | 3.8 | 204 | Citations (PDF) |
| 150 | Decreased expression of peroxisome proliferator‐activated receptor α and liver fatty acid binding protein after partial hepatectomy of rats and mice | 3.9 | 17 | Citations (PDF) |
| 151 | Kinase signaling cascades that modulate peroxisome proliferator-activated receptors | 3.9 | 61 | Citations (PDF) |
| 152 | PixFRET, an ImageJ plug-in for FRET calculation that can accommodate variations in spectral bleed-throughs | 2.1 | 216 | Citations (PDF) |
| 153 | Pancreatic Islet Adaptation to Fasting Is Dependent on Peroxisome Proliferator-Activated Receptor α Transcriptional Up-Regulation of Fatty Acid Oxidation | 2.5 | 90 | Citations (PDF) |
| 154 | Peroxisome proliferator-activated receptor ?/? activation inhibits hypertrophy in neonatal rat cardiomyocytes | 5.5 | 163 | Citations (PDF) |
| 155 | Selective Expression of a Dominant-Negative Form of Peroxisome Proliferator-Activated Receptor in Keratinocytes Leads to Impaired Epidermal Healing | 2.5 | 30 | Citations (PDF) |
| 156 | Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator–activated receptor-γ | 9.3 | 489 | Citations (PDF) |
| 157 | Peroxisome proliferator-activated receptor β/δ as a therapeutic target for metabolic diseases | 3.7 | 40 | Citations (PDF) |
| 158 | Epithelium-Mesenchyme Interactions Control the Activity of Peroxisome Proliferator-Activated Receptor β/δ during Hair Follicle Development | 2.5 | 59 | Citations (PDF) |
| 159 | Fluorescence Imaging Reveals the Nuclear Behavior of Peroxisome Proliferator-activated Receptor/Retinoid X Receptor Heterodimers in the Absence and Presence of Ligand*♦ | 2.2 | 114 | Citations (PDF) |
| 160 | Transcriptional Repression of Peroxisome Proliferator-activated Receptor β/δ in Murine Keratinocytes by CCAAT/Enhancer-binding Proteins* | 2.2 | 44 | Citations (PDF) |
| 161 | Dosage-Dependent Effects of Akt1/Protein Kinase Bα (PKBα) and Akt3/PKBγ on Thymus, Skin, and Cardiovascular and Nervous System Development in Mice | 2.5 | 210 | Citations (PDF) |
| 162 | Microsomal Triglyceride Transfer Protein Promotes the Secretion of Xenopus laevis Vitellogenin A1 | 2.2 | 32 | Citations (PDF) |
| 163 | Promoter Rearrangements Cause Species-specific Hepatic Regulation of the Glyoxylate Reductase/Hydroxypyruvate Reductase Gene by the Peroxisome Proliferator-activated Receptor α | 2.2 | 22 | Citations (PDF) |
| 164 | Multiple expression control mechanisms of peroxisome proliferator-activated receptors and their target genes | 2.3 | 121 | Citations (PDF) |
| 165 | Functional role of RXRs and PPARγ in mature adipocytes | 2.7 | 45 | Citations (PDF) |
| 166 | Genetic- or Transforming Growth Factor-β1-induced Changes in Epidermal Peroxisome Proliferator-activated Receptor β/δ Expression Dictate Wound Repair Kinetics | 2.2 | 38 | Citations (PDF) |
| 167 | Be Fit or Be Sick: Peroxisome Proliferator-Activated Receptors Are Down the Road | 2.5 | 202 | Citations (PDF) |
| 168 | Altered Growth in Male Peroxisome Proliferator-Activated Receptor γ (PPARγ) Heterozygous Mice: Involvement of PPARγ in a Negative Feedback Regulation of Growth Hormone Action | 2.5 | 37 | Citations (PDF) |
| 169 | Regional variations in ABC transporter expression along the mouse intestinal tract | 2.4 | 53 | Citations (PDF) |
| 170 | The Direct Peroxisome Proliferator-activated Receptor Target Fasting-induced Adipose Factor (FIAF/PGAR/ANGPTL4) Is Present in Blood Plasma as a Truncated Protein That Is Increased by Fenofibrate Treatment | 2.2 | 242 | Citations (PDF) |
| 171 | Impaired expression of NADH dehydrogenase subunit 1 and PPARγ coactivator-1 in skeletal muscle of ZDF rats | 3.6 | 58 | Citations (PDF) |
| 172 | Peroxisome proliferator-activated receptor is required in mature white and brown adipocytes for their survival in the mouse | 7.5 | 369 | Citations (PDF) |
| 173 | Peroxisome proliferator-activated receptor-β as a target for wound healing drugs | 3.7 | 40 | Citations (PDF) |
| 174 | Peroxisome-Proliferator-Activated Receptor (PPAR)-γ Activation Stimulates Keratinocyte Differentiation | 2.3 | 189 | Citations (PDF) |
| 175 | Peroxisome-proliferator-activated receptors and cancers: complex stories | 60.7 | 570 | Citations (PDF) |
| 176 | In vivo activation of PPAR target genes by RXR homodimers | 7.3 | 183 | Citations (PDF) |
| 177 | Essential role of Smad3 in the inhibition of inflammation-induced PPARβ/δ expression | 7.3 | 80 | Citations (PDF) |
| 178 | Lack of hypotriglyceridemic effect of gemfibrozil as a consequence of age-related changes in rat liver PPARα | 5.1 | 40 | Citations (PDF) |
| 179 | Functions of peroxisome proliferator-activated receptors (PPAR) in skin homeostasis | 1.3 | 51 | Citations (PDF) |
| 180 | PPARα governs glycerol metabolism | 10.6 | 222 | Citations (PDF) |
| 181 | PPARα governs glycerol metabolism | 10.6 | 127 | Citations (PDF) |
| 182 | Peroxisome proliferator-activated receptor-? as a target for wound healing drugs | 3.7 | 4 | Citations (PDF) |
| 183 | Peroxisome proliferator-activated receptor-β signaling contributes to enhanced proliferation of hepatic stellate cells | 0.9 | 134 | Citations (PDF) |
| 184 | The anti-apoptotic role of PPARβ contributes to efficient skin wound healing | 2.3 | 66 | Citations (PDF) |
| 185 | PPARβ regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation | 3.6 | 62 | Citations (PDF) |
| 186 | Sex Difference in Hepatic Peroxisome Proliferator-Activated Receptor α Expression: Influence of Pituitary and Gonadal Hormones | 2.5 | 125 | Citations (PDF) |
| 187 | Peroxisome proliferator-activated receptors β/δ: emerging roles for a previously neglected third family member | 4.0 | 50 | Citations (PDF) |
| 188 | Selective Cooperation between Fatty Acid Binding Proteins and Peroxisome Proliferator-Activated Receptors in Regulating Transcription | 2.5 | 476 | Citations (PDF) |
| 189 | Differential Regulation of Vascular Endothelial Growth Factor Expression by Peroxisome Proliferator-activated Receptors in Bladder Cancer Cells | 2.2 | 101 | Citations (PDF) |
| 190 | A New Selective Peroxisome Proliferator-Activated Receptor γ Antagonist with Antiobesity and Antidiabetic Activity | 2.5 | 208 | Citations (PDF) |
| 191 | Antiapoptotic Role of PPARβ in Keratinocytes via Transcriptional Control of the Akt1 Signaling Pathway | 13.3 | 641 | Citations (PDF) |
| 192 | PPARs: transcriptional effectors of fatty acids and their derivatives | 5.5 | 295 | Citations (PDF) |
| 193 | Looking at nuclear receptors from the heights of Erice | 5.2 | 9 | Citations (PDF) |
| 194 | Impaired skin wound healing in peroxisome proliferator–activated receptor (PPAR)α and PPARβ mutant mice | 5.4 | 404 | Citations (PDF) |
| 195 | Critical roles of PPARbeta /delta in keratinocyte response to inflammation | 4.6 | 378 | Citations (PDF) |
| 196 | Differential involvement of peroxisome-proliferator-activated receptors α and δ in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine | 3.8 | 143 | Citations (PDF) |
| 197 | Attenuation of Colon Inflammation through Activators of the Retinoid X Receptor (Rxr)/Peroxisome Proliferator–Activated Receptor γ (Pparγ) Heterodimer | 9.3 | 431 | Citations (PDF) |
| 198 | The peroxisome proliferator‐activated receptor α regulates amino acid metabolism | 0.6 | 205 | Citations (PDF) |
| 199 | Rat PPARs: Quantitative Analysis in Adult Rat Tissues and Regulation in Fasting and Refeeding | 2.5 | 448 | Citations (PDF) |
| 200 | Expression and Localization of PPARs in the Rat Ovary During Follicular Development and the Periovulatory Period | 2.5 | 135 | Citations (PDF) |
| 201 | Roles of PPARs in health and disease | 37.9 | 1,861 | Citations (PDF) |
| 202 | Peroxisome proliferator-activated receptors: insight into multiple cellular functions | 1.8 | 429 | Citations (PDF) |
| 203 | Estrogenic activity assessment of environmental chemicals using in vitro assays: identification of two new estrogenic compounds. | 8.3 | 59 | Citations (PDF) |
| 204 | Characterization of the Fasting-induced Adipose Factor FIAF, a Novel Peroxisome Proliferator-activated Receptor Target Gene | 2.2 | 526 | Citations (PDF) |
| 205 | Activation of Peroxisome Proliferator-Activated Receptors (PPARs) by Their Ligands and Protein Kinase A Activators | 2.5 | 202 | Citations (PDF) |
| 206 | Determinants of Vitellogenin B1 Promoter Architecture | 2.2 | 37 | Citations (PDF) |
| 207 | Nuclear Hormone Receptor Coregulators In Action: Diversity For Shared Tasks | 2.5 | 351 | Citations (PDF) |
| 208 | An immuno-electron microscopical analysis of transcribing multinucleosomal templates: what happens to the histones? 1 1Edited by W. Baumeister | 4.1 | 13 | Citations (PDF) |
| 209 | Activation of Peroxisome Proliferator-Activated Receptors (PPARs) by Their Ligands and Protein Kinase A Activators | 2.5 | 68 | Citations (PDF) |
| 210 | Nuclear Hormone Receptor Coregulators In Action: Diversity For Shared Tasks | 2.5 | 119 | Citations (PDF) |
| 211 | Activation of the Mouse TATA-less and Human TATA-Containing UDP-Glucuronosyltransferase1A1Promoters by Hepatocyte Nuclear Factor 1 | 2.6 | 65 | Citations (PDF) |
| 212 | Chemical Probes That Differentially Modulate Peroxisome Proliferator-activated Receptor α and BLTR, Nuclear and Cell Surface Receptors for Leukotriene B4 | 2.2 | 44 | Citations (PDF) |
| 213 | Peroxisome Proliferator-activated Receptor β Regulates Acyl-CoA Synthetase 2 in Reaggregated Rat Brain Cell Cultures | 2.2 | 118 | Citations (PDF) |
| 214 | Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions | 6.8 | 188 | Citations (PDF) |
| 215 | Steroid and nuclear receptors Villefranche-sur-Mer, France, May 25–27, 1999 | 7.3 | 73 | Citations (PDF) |
| 216 | Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism* | 24.6 | 2,469 | Citations (PDF) |
| 217 | Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting | 10.6 | 1,532 | Citations (PDF) |
| 218 | Activation of the Mouse TATA-less and Human TATA-Containing UDP-Glucuronosyltransferase 1A1 Promoters by Hepatocyte Nuclear Factor | 2.6 | 0 | Citations (PDF) |
| 219 | Regulation of the vitellogenin gene B1 promoter after transfer into hepatocytes in primary cultures | 3.4 | 13 | Citations (PDF) |
| 220 | The peroxisome proliferator-activated receptors at the cross-road of diet and hormonal signalling | 2.3 | 86 | Citations (PDF) |
| 221 | Do Peroxisome Proliferating Compounds Pose a Hepatocarcinogenic Hazard to Humans? | 3.0 | 215 | Citations (PDF) |
| 222 | Functional Interaction between the Estrogen Receptor and CTF1: Analysis of the Vitellogenin Gene B1 Promoter in Yeast | 2.5 | 7 | Citations (PDF) |
| 223 | Differential Expression of Peroxisome Proliferator-Activated Receptor-α, -β, and -γ during Rat Embryonic Development* | 2.5 | 425 | Citations (PDF) |
| 224 | Functional Interaction between the Estrogen Receptor and CTF1: Analysis of the Vitellogenin Gene B1 Promoter in Yeast | 2.5 | 1 | Citations (PDF) |
| 225 | Functional Interactions between the Estrogen Receptor and the Transcription Activator Sp1 Regulate the Estrogen-dependent Transcriptional Activity of the Vitellogenin A1 ioPromoter | 2.2 | 66 | Citations (PDF) |
| 226 | Fatty Acids, Eicosanoids, and Hypolipidemic Agents Identified as Ligands of Peroxisome Proliferator-Activated Receptors by Coactivator-Dependent Receptor Ligand Assay | 2.5 | 1,108 | Citations (PDF) |
| 227 | Polarity and Specific Sequence Requirements of Peroxisome Proliferator-activated Receptor (PPAR)/Retinoid X Receptor Heterodimer Binding to DNA | 2.2 | 322 | Citations (PDF) |
| 228 | PPARα Structure-Function Relationships Derived from Species-Specific Differences in Responsiveness to Hypolipidemic Agents | 2.1 | 91 | Citations (PDF) |
| 229 | Transcriptional Regulation by Triiodothyronine of the UDP-glucuronosyltransferase Family 1 Gene Complex in Rat Liver | 2.2 | 17 | Citations (PDF) |
| 230 | DNA Binding Properties of Peroxisome Proliferator-activated Receptor Subtypes on Various Natural Peroxisome Proliferator Response Elements | 2.2 | 342 | Citations (PDF) |
| 231 | Retinoid X receptor and peroxisome proliferator-activated receptor activate an estrogen responsive gene independent of the estrogen receptor | 3.4 | 92 | Citations (PDF) |
| 232 | Peroxisome proliferator-activated receptor agonists | 5.8 | 189 | Citations (PDF) |
| 233 | Fatty Acids, Eicosanoids, and Hypolipidemic Agents Identified as Ligands of Peroxisome Proliferator-Activated Receptors by Coactivator-Dependent Receptor Ligand Assay | 2.5 | 387 | Citations (PDF) |
| 234 | Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. | 2.5 | 2,053 | Citations (PDF) |
| 235 | PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS: A Nuclear Receptor Signaling Pathway in Lipid Physiology | 9.6 | 677 | Citations (PDF) |
| 236 | PPAR Tissue Distribution and Interactions with Other Hormone-Signaling Pathways | 4.0 | 152 | Citations (PDF) |
| 237 | The PPARα–leukotriene B4 pathway to inflammation control | 37.9 | 1,370 | Citations (PDF) |
| 238 | The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin. | 2.5 | 170 | Citations (PDF) |
| 239 | Expression of the Peroxisome Proliferator-activated Receptor α Gene Is Stimulated by Stress and Follows a Diurnal Rhythm | 2.2 | 310 | Citations (PDF) |
| 240 | Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat | 2.5 | 734 | Citations (PDF) |
| 241 | The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin | 2.5 | 70 | Citations (PDF) |
| 242 | Multimeric complexes of the PML-retinoic acid receptor alpha fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxisome-proliferator signaling pathways. | 7.5 | 86 | Citations (PDF) |
| 243 | Induction of the Acyl-Coenzyme A Synthetase Gene by Fibrates and Fatty Acids Is Mediated by a Peroxisome Proliferator Response Element in the C Promoter | 2.2 | 354 | Citations (PDF) |
| 244 | Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists. | 7.5 | 122 | Citations (PDF) |
| 245 | Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more… | 4.7 | 267 | Citations (PDF) |
| 246 | Fate of linear and supercoiled multinucleosomic templates during transcription. | 7.3 | 22 | Citations (PDF) |
| 247 | Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements. | 2.5 | 181 | Citations (PDF) |
| 248 | Functional interactions of peroxisome proliferator-activated receptor, retinoid-X receptor, and Sp1 in the transcriptional regulation of the acyl-coenzyme-A oxidase promoter. | 2.5 | 60 | Citations (PDF) |
| 249 | A proline-rich TGF-beta-responsive transcriptional activator interacts with histone H3. | 4.6 | 131 | Citations (PDF) |
| 250 | Peroxisome Proliferator-activated Receptor Mediates Cross-talk with Thyroid Hormone Receptor by Competition for Retinoid X Receptor | 2.2 | 149 | Citations (PDF) |
| 251 | Peroxisome proliferator-activated receptors: finding the orphan a home | 3.4 | 165 | Citations (PDF) |
| 252 | Gene transfer into Xenopus hepatocytes: transcriptional regulation by members of the nuclear receptor superfamily | 3.4 | 6 | Citations (PDF) |
| 253 | Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids. | 2.2 | 217 | Citations (PDF) |
| 254 | Two functional forms of the Xenopus laevis estrogen receptor translated from a single mRNA species. | 2.2 | 21 | Citations (PDF) |
| 255 | Complex organization of CTF/NF-I, C/EBP, and HNF3 binding sites within the promoter of the liver-specific vitellogenin gene | 2.2 | 51 | Citations (PDF) |
| 256 | FTZ-F1-Related Orphan Receptors in
Xenopus laevis
: Transcriptional Regulators Differentially Expressed During Early Embryogenesis | 2.5 | 17 | Citations (PDF) |
| 257 | Positive regulation of the peroxisomal β-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR) | 2.6 | 261 | Citations (PDF) |
| 258 | Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. | 7.5 | 891 | Citations (PDF) |
| 259 | Xenopus peroxisome proliferator activated receptors: Genomic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids | 2.3 | 94 | Citations (PDF) |
| 260 | Peroxisome proliferator-activated receptors A link between endocrinology and nutrition? | 8.5 | 82 | Citations (PDF) |
| 261 | Peroxisome Proliferator-Activated Receptors and Lipid Metabolism | 4.0 | 88 | Citations (PDF) |
| 262 | A nucleosome-dependent static loop potentiates estrogen-regulated transcription from the Xenopus vitellogenin B1 promoter in vitro. | 7.3 | 208 | Citations (PDF) |
| 263 | Inhibition of Estrogen-Responsive Gene Activation by the Retinoid X Receptor β: Evidence for Multiple Inhibitory Pathways | 2.5 | 23 | Citations (PDF) |
| 264 | Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors | 33.6 | 1,330 | Citations (PDF) |
| 265 | The apical localization of transcribing RNA polymerases on supercoiled DNA prevents their rotation around the template. | 7.3 | 94 | Citations (PDF) |
| 266 | A common ancestor DNA motif for invertebrate and vertebrate hormone response elements. | 7.3 | 89 | Citations (PDF) |
| 267 | A Liver Protein Fraction Regulating Hormone-Dependentin VitroTranscription from the Vitellogenin Genes Induces Their Expression in Xenopus Oocytes | 2.5 | 14 | Citations (PDF) |
| 268 | PCR driven DNA-DNA competitive hybridization: a new method for sensitive differential cloning | 15.5 | 22 | Citations (PDF) |
| 269 | Ribosomal protein L27 is identical in chick and rat | 15.5 | 23 | Citations (PDF) |
| 270 | Synergistic Transcriptional Activation by CTF/NF-I and the Estrogen Receptor Involves Stabilized Interactions with a Limiting Target Factor | 2.5 | 32 | Citations (PDF) |
| 271 | Estrogen receptor level determines sex-specific in vitro transcription from the Xenopus vitellogenin promoter. | 7.5 | 34 | Citations (PDF) |
| 272 | Transcriptional Potentiation of the Vitellogenin B1 Promoter by a Combination of Both Nucleosome Assembly and Transcription Factors: an In Vitro Dissection | 2.5 | 16 | Citations (PDF) |
| 273 | Cooperative binding of estrogen receptor to imperfect estrogen-responsive DNA elements correlates with their synergistic hormone-dependent enhancer activity. | 7.3 | 164 | Citations (PDF) |
| 274 | Identification of Two Steroid-Responsive Promoters of Different Strength Controlled by the Same Estrogen-Responsive Element in the 5′-End Region of theXenopus laevisVitellogenin Gene A1 | 2.5 | 5 | Citations (PDF) |
| 275 | Amphibian albumins as members of the albumin, alpha-fetoprotein, vitamin D-binding protein multigene family | 1.7 | 56 | Citations (PDF) |
| 276 | Cis- and trans-acting elements of the estrogen-regulated vitellogenin gene B1 of Xenopus laevis | 1.0 | 27 | Citations (PDF) |
| 277 | A Nuclear Factor I-Like Activity and a Liver-Specific Repressor Govern Estrogen-Regulated In Vitro Transcription from the Xenopus laevis Vitellogenin Bl Promoter | 2.5 | 29 | Citations (PDF) |
| 278 | Evolution and expression of vitellogenin genes | 9.8 | 231 | Citations (PDF) |
| 279 | Immuno-electron microscopic identification of human estrogen receptor-DNA complexes at the estrogen-responsive element and in the first intron of a Xenopus vitellogenin gene | 4.1 | 10 | Citations (PDF) |
| 280 | The human estrogen receptor can regulate exogenous but not endogenous vitellogenin gene promoters in aXenopuscell line | 15.5 | 30 | Citations (PDF) |
| 281 | Expression of human estrogen receptor mutants in Xenopus oocytes: correlation between transcriptional activity and ability to form protein-DNA complexes. | 7.3 | 38 | Citations (PDF) |
| 282 | The N-terminal DNA-binding ‘zinc finger’ of the oestrogen and glucocorticoid receptors determines target gene specificity. | 7.3 | 245 | Citations (PDF) |
| 283 | Precursor-product relationship between vitellogenin and the yolk proteins as derived from the complete sequence of aXenopusvitellogenin gene | 15.5 | 125 | Citations (PDF) |
| 284 | Vertebrate and nematode genes coding for yolk proteins are derived from a common ancestor | 2.4 | 70 | Citations (PDF) |
| 285 | Complementary DNA cloning of complement C8.beta. and its sequence homology to C9 | 2.4 | 78 | Citations (PDF) |
| 286 | Electron microscopic visualization of protein-DNA interactions at the estrogen responsive element and in the first intron of the Xenopus laevis vitellogenin gene. | 7.3 | 25 | Citations (PDF) |
| 287 | The estrogen-responsive element as an inducible enhancer: DNA sequence requirements and conversion to a glucocorticoid-responsive element. | 7.3 | 258 | Citations (PDF) |
| 288 | The distribution of the dinucleotide CpG and cytosine methylation in the vitellogenin gene family | 1.7 | 17 | Citations (PDF) |
| 289 | Comparison of the organization and fine structure of a chicken and a Xenopus laevis vitellogenin gene. | 2.2 | 50 | Citations (PDF) |
| 290 | Transposition of a bacterial IS3 element into aXenopusVi-element | 15.5 | 1 | Citations (PDF) |
| 291 | Identification of estrogen-responsive DNA sequences by transient expression experiments in a human breast cancer cell line | 15.5 | 180 | Citations (PDF) |
| 292 | Linkage arrangement in the vitellogenin gene family ofXenopus laevisas revealed by gene segregation analysis | 15.5 | 24 | Citations (PDF) |
| 293 | Visualization of RNA polymerase II ternary transcription complexes formed in vitro on a Xenopus laevis vitellogenin gene. | 7.3 | 18 | Citations (PDF) |
| 294 | The Vi element | 4.1 | 23 | Citations (PDF) |
| 295 | Evolution of vitellogeain genes: comparative analysis of the nucleotide sequences downstream of the transcription initiation site of fourXenopus laevisand one chicken gene | 15.5 | 47 | Citations (PDF) |
| 296 | Sequence homologies in the region preceding the transcription initiation site of the liver estrogen-responsive vitellogenin and apo-VLDLII genes | 15.5 | 259 | Citations (PDF) |
| 297 | Injection of partially purified estrogen receptor protein from Xenopus liver nuclei into oocytes activates the silent vitellogenin locus. | 7.5 | 19 | Citations (PDF) |
| 298 | Scattering of repetitive DNA sequences in the albumin and vitellogenin gene loci ofXenopus laevis | 15.5 | 11 | Citations (PDF) |
| 299 | VlteBogtnin B2 gene inXenopus laevis: Isolation,in vitrotranscription and relation to other vitellogenin genes | 15.5 | 44 | Citations (PDF) |
| 300 | Vitellogenin genes A1 and B1 are linked in the Xenopus laevis genome. | 7.5 | 45 | Citations (PDF) |
| 301 | Transcription of single-copy vitellogenin gene of Xenopus involves expression of middle repetitive DNA | 37.9 | 23 | Citations (PDF) |
| 302 | Isolation of two closely related vitellogenin genes, including their flanking regions, from a Xenopus laevis gene library. | 7.5 | 70 | Citations (PDF) |
| 303 | Isolation and Translation in vitro of Four Related Vitellogenin mRNAs of Estrogen-Stimulated Xenopus laevis | 0.2 | 39 | Citations (PDF) |
| 304 | Comparative analysis of the structural organization of two closely related vitellogenin genes in X. laevis | 33.6 | 111 | Citations (PDF) |
| 305 | Application of recombinant DNA technology to questions of developmental biology: A review | 1.9 | 63 | Citations (PDF) |
| 306 | Vitellogenin in Xenopus laevis is encoded in a small family of genes | 33.6 | 230 | Citations (PDF) |
| 307 | Retention of the differentiated state by larvalXenopus liver cells in primary culture | 1.1 | 8 | Citations (PDF) |
| 308 | Electron-Microscopic Demonstration of Terminal and Internal Initiation Sites for cDNA Synthesis on Vitellogenin mRNA | 0.2 | 22 | Citations (PDF) |
| 309 | Cloning and characterization of synthetic sequences from the Xenopus laevis vitellogenin structural gene | 1.9 | 61 | Citations (PDF) |
| 310 | Quantitation of vitellogenin messenger RNA in the liver of male xenopus toads during primary and secondary stimulation by estrogen | 33.6 | 108 | Citations (PDF) |
| 311 | Factors promoting the establishment of primary cultures of liver cells fromXenopus larvae | 1.1 | 5 | Citations (PDF) |
| 312 | Size, Complexity and Abundance of a Specific Poly(A)-Containing RNA of Liver from Male Xenopus Induced to Vitellogenin Synthesis by Estrogen | 0.2 | 66 | Citations (PDF) |
| 313 | Glucocorticoid receptor-PPARα axis in fetal mouse liver prepares neonates for milk lipid catabolism | 0.7 | 46 | Citations (PDF) |
| 314 | PPARβ/δ contributes to the antidiabetic effect and the increase in GDF15 caused by metformin | 7.1 | 0 | Citations (PDF) |
| 315 | Peroxisome Proliferator-Activated Receptor β/δ: A Link Between Metabolism, Inflammation, and Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease | 4.6 | 1 | Citations (PDF) |
| 316 | Palmitic and oleic acids in type 2 diabetes mellitus | 8.5 | 0 | Citations (PDF) |
| 317 | The emerging role of PPARs in primary biliary cholangitis | 7.4 | 0 | Citations (PDF) |
